Venus Remedies' VRP-034 Earns Elite QIDP Status from US FDA, Enriching Global Antimicrobial Effort

Unknown Apr 02, 2026 850 Views

Venus Remedies Ltd has reported a significant milestone with its new antimicrobial drug VRP-034 earning the prestigious Qualified Infectious Disease Product (QIDP) status from the U.S. Food and Drug Administration (FDA). This designation clears the way for accelerated development and review of th...